The ResApp Health Ltd (ASX: RAP) share price won’t be going anywhere on Tuesday.
This comes as the company requested its shares be placed in a trading halt.
At the time of writing, shares in the digital health company are frozen at 11 cents apiece.
Details of the ResApp share price halt
Prior to the market opening, the company requested trading in its shares be halted while it prepares an announcement.
According to the company’s release, ResApp is planning to provide an update regarding a proposed acquisition by Pfizer Australia.
The global biopharmaceutical giant offered to purchase ResApp for 11.5 cents per share in cash. In total, this represents an equity value of around $100 million.
Following the proposal, ResApp’s directors unanimously recommended its shareholders vote in favour of the scheme of arrangement.
However, for the deal to go ahead, certain regulatory approvals need to be met. This includes being given the nod from the Australian Competition and Consumer Commission (ACCC).
ResApp has requested the trading halt remains in place until Thursday 2 June or when the announcement is made, whichever comes first.
Quick take on ResApp
ResApp is a digital health company that specialises in developing smartphone apps for the diagnostics and management of respiratory diseases.
Machine learning algorithms use sound to detect and measure a variety of breathing conditions, such as restricted breathing, snoring, and coughing.
Its regulatory-approved products include ResAppDx and SleepCheck, which are both approved for sale and marketing in Australia and Europe.
ResApp share price snapshot
Since this time last year, ResApp shares have more than doubled in value to register a gain of around 110%.
In 2022, the company’s shares are 70% higher on the back of the Pfizer takeover offer.
Based on valuation grounds, ResApp presides a market capitalisation of roughly $94.5 million.
The post ResApp share price halted ahead of Pfizer takeover update appeared first on The Motley Fool Australia.
Should you invest $1,000 in ResApp right now?
Before you consider ResApp, you’ll want to hear this.
Motley Fool Investing expert Scott Phillips just revealed what he believes are the 5 best stocks for investors to buy right now… and ResApp wasn’t one of them.
The online investing service he’s run for over a decade, Motley Fool Share Advisor, has provided thousands of paying members with stock picks that have doubled, tripled or even more.* And right now, Scott thinks there are 5 stocks that are better buys.
*Returns as of January 13th 2022
More reading
- Do you dare take on this bold challenge from Warren Buffett?
- Why is the Beach Energy share price having such a cracking Tuesday?
- Broker gives its verdict on the Woodside share price post-merger
- 10 reasons Warren Buffett is such a successful investor
- 3 quality ASX 200 shares with dividend reinvestment plans
Motley Fool contributor Aaron Teboneras has no position in any of the stocks mentioned. The Motley Fool Australia’s parent company Motley Fool Holdings Inc. has no position in any of the stocks mentioned. The Motley Fool Australia has no position in any of the stocks mentioned. The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Bruce Jackson.
from The Motley Fool Australia https://ift.tt/t4pxuYU
Leave a Reply